help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
This version published online on April 29, 2008
Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2007-2530
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
93/7/2693    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maalouf, J.
Right arrow Articles by El-Hajj Fuleihan, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maalouf, J.
Right arrow Articles by El-Hajj Fuleihan, G.
Related Collections
Right arrow Pediatric Endocrinology
Right arrow Calcium and Bone Metabolism

Submitted on November 14, 2007
Accepted on April 18, 2008

SHORT-TERM AND LONG-TERM SAFETY OF WEEKLY HIGH-DOSE VITAMIN D3 SUPPLEMENTATION IN SCHOOL CHILDREN

Joyce Maalouf, Mona Nabulsi, Reinhold Vieth, Samantha Kimball, Rola El-Rassi, Ziyad Mahfoud, and Ghada El-Hajj Fuleihan*

Calcium Metabolism and Osteoporosis Program, Department of Internal Medicine, Department of Pediatrics, School of Medicine, American University of Beirut, Beirut, Lebanon; Department of Nutritional Sciences, Department of Laboratory Medicine, University of Toronto, Toronto, Canada; Department of Epidemiology and Population Health, School of Health Sciences, American University of Beirut, Beirut, Lebanon

* To whom correspondence should be addressed. E-mail: gf01{at}aub.edu.lb.

Background: Hypovitaminosis D is prevalent in youth worldwide, but the safety of vitamin D at doses exceeding 200 IU/day is unknown in this age group. We assessed the safety of high doses of vitamin D3 administered to apparently healthy school children.

Methods: short term safety: 25 subjects randomly received placebo or vitamin D3 at doses of 14,000 IU/wk for 8 weeks. Long term safety: 340 subjects randomly received placebo, vitamin D3 as 1400 IU or 14,000 IU/week for one year. Biochemical variables were monitored at 0, 2, 4, 6, 8 weeks, and 8 weeks off therapy in the short term study and at 0, 6 and 12 months in the long term study.

Results: In both the short term and long term studies, mean serum calcium and 1,25-OHD levels did not change in any group. In the short term study, mean 25-OHD concentrations increased from 44 (± 11) ng/ml to 54 (± 19) ng/ml in the treated groups (P=0.033). In the long term study, mean 25-OHD levels increased from 15±8 to 19±7 ng/ml (p<0.0001) in subjects receiving 1400 IU/wk; and from 15±7 to 36±22ng/ml in the group receiving 14,000 IU/wk (p<0.0001). No subject developed vitamin D intoxication.

Conclusion: Vitamin D3 at doses equivalent to 2,000 IU/day for one year is safe in adolescents and results in desirable vitamin D levels.
Key words: safety • recommendations • daily allowance • hypovitaminosis D • children




This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
J. H. Lee, J. H. O'Keefe, D. Bell, D. D. Hensrud, and M. F. Holick
Vitamin D Deficiency: An Important, Common, and Easily Treatable Cardiovascular Risk Factor?
J. Am. Coll. Cardiol., December 9, 2008; 52(24): 1949 - 1956.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society